YM 161514
Alternative Names: YM 151; YM 161511Latest Information Update: 22 Dec 2000
At a glance
- Originator Yamanouchi
- Class Antiarrhythmics; Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Angina pectoris; Hypertension
Most Recent Events
- 22 Dec 2000 No-Development-Reported for Angina pectoris in European Union (Unknown route)
- 22 Dec 2000 No-Development-Reported for Angina pectoris in USA (Unknown route)
- 22 Dec 2000 No-Development-Reported for Hypertension in European Union (PO)